SCHEMBL29614732

SCHEMBL29614732

Cn1nc(NS(=O)(=O)c2ccccc2)cc1-c1ccc2cc(N)ncc2c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PIK3CG P48736 5/20 0.44
▸ PIK3CD O00329 1/20 0.42
▸ LMNA P02545 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ BRAF P15056 1/20 0.39
▸ ALOX5AP P20292 1/20 0.38
▸ FEN1 P39748 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ HSD11B1 P28845 2/20 0.37
▸ PIK3CB P42338 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ NPY5R Q15761 1/20 0.37
▸ GLA P06280 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ ABL1 P00519 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19307151 1.00 PIK3CG (0.44) PIK3CGPIK3CDLMNACYP2C9BRAF
SCHEMBL29614806 0.79 ABL1 (0.48) ABL1
SCHEMBL19307114 0.79 ABL1 (0.48) ABL1
SCHEMBL19316702 0.79 ABL1 (0.38) PIK3CGPIK3CDBRAFPIK3CBABL1
SCHEMBL19307113 0.71 TSHR (0.49) PIK3CBTSHR
SCHEMBL29614849 0.71 TSHR (0.49) PIK3CBTSHR
SCHEMBL20214697 0.68 ABL1 (0.52) ABL1
SCHEMBL14244848 0.67 PDPK1 (0.62) LMNAKDM4EALDH1A1HPGDHSD17B10
SCHEMBL4511353 0.65 PIK3C3 (0.52) PIK3CGPIK3CDPIK3CB
SCHEMBL25350247 0.64 FFAR4 (0.50) LMNACYP2C9KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220160705-A1 METHODS FOR CONTROLLING PROSTAGLANDIN-MEDIATED BIOLOGICAL PROCESSES CORNELL UNIVERSITY 2022-05-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220160705-A1 METHODS FOR CONTROLLING PROSTAGLANDIN-MEDIATED BIOLOGICAL PROCESSES PTGES, PTGS1, PTGES2 PIK3CG 3811/4885PIK3CD 4702/4885LMNA 2938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback